Table 1.
Baseline features at transplant
|
Characteristics Variable |
All patients (n = 431) Median (range) |
Early transplant (n = 264) Median (range) |
Late transplant (n = 167) Median (range) |
|---|---|---|---|
| Age at diagnosis | 56.6 (24–73) | 57.7 (32–73) | 54.4 (24–73) |
| Age at transplant | 57.8 (33–75) | 58.2 (33–73) | 57.1 (33–75) |
| Time to transplant (months) | 7.7 (3–196) | 6.2 (3–11.8) | 31.1 (12.1–196) |
| Serum M protein level | 2 (0–10.4) | 1.9 (0–6.9) | 2.3 (0–10.4) |
| BM plasma cell (%) | 21 (0–95) | 17 (0–95) | 29 (0–95) |
| Creatinine | 1.1 (0.6–10) | 1.1 (0.6–10) | 1.1 (0.6–2.8) |
| Gender: male (%) | 64 | 61.9 | 67.5 |
| Durie salmon stage (%) | |||
| 2 | 29.2 | 31.7 | 25.1 |
| 3 | 70.3 | 68.3 | 74.9 |
| Relapse/refractory (%) | 66.5 | 48.2 | 95.9 |
| PCLI >=1% (%) | 36.7 | 29.1 | 48.8 |
| β2 Microglobulin > 3.5 (%) | 12.9 | 12.3 | 13.9 |
| Bone disease (%) | 84.7 | 83.3 | 87 |
| Abnormal cytogenetics (%) | 30.3 | 23.8 | 40.9 |
Abbreviation: PCLI =plasma cell labeling index.